Awarded contract

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

Details

Buyer: NHS England
Supplier(s): 9 suppliers
Bio Products Laboratory
CSL Behring (UK) Ltd
LFB
Novo Nordisk Ltd
Octapharma Ltd
Pfizer Liimted
Roche Products Ltd
Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
Takeda UK Limited
Value: GBP 765,000,000
Duration: 3 years
Topic: Pharmaceutical products
Published: 11 June 2024
Source: uk:contracts_finder

Tender description

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024 Offer reference number: CM/PHS/22/5661 Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Timeline

Completed: Award published11 June 2024
Current notice
Completed: Award date1 July 2024
Next: Contract expiry date30 April 2027in 8 months

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov